HELP Stock Slides As Suicide Attempt Overshadows Strong Late-stage Depression Trial Data
Why Is HELP Stock Rising Today?
Helus Pharma Shares Fall 21% Despite Phase 3 HLP003 Trial Meeting Primary Endpoint
Helus Pharma stock tumbles 21% despite positive trial results
Helus Pharma Q2 EPS $(1.41) Misses $(0.64) Estimate
Helus Pharma Announces Topline Results From Its APPROACH Phase 3 Study Evaluating HLP003 For Adults With Major Depressive Disorder; 7.6 Point Placebo-Adjusted Change From Baseline At Week 6 For The Primary Endpoint; Durable Effect Maintained Through Week 12; Generally Well-Tolerated, With Three HLP003 Treatment-Related Serious Adverse Events
Helus Pharma to Present Topline Results from Phase 3 APPROACH Study Evaluating HLP003 as Adjunctive Treatment in Major Depressive Disorder on November 16, 2026
Helus Pharma (HELP) Could Be 78% Below Fair Value After Conference Spotlight
Is Helus Pharma (HELP) Trading At A Premium To Book Value?
Helus Pharma to Participate in the Guggenheim Healthcare Innovation Conference
Helus Pharma Appoints Mark Lawson As Board Chair, Effective Immediately
Helus Pharma Inc. (HELP) Discusses Clinical Pipeline and Phase 3 Strategies for Novel Serotonergic Agonists in Mental Health - Slideshow
Helus Pharma Highlights Clinical Program Advancements at Investor Presentation Held on October 21, 2026
Cybin Eyes Q4 Phase III Depression Data as Anxiety Program Advances
Cybin Inc. (HELP) Upgraded to Buy: What Does It Mean for the Stock?
Helus Pharma Announces Completion of Legal Name Change
Cybin (HELP) Stock May Be Trading At A Premium Despite Fresh Depression Trial Data
Cybin (HELP) Shares Moved, What Is Behind The Fresh Attention?
Helus Pharma Announces Results of Annual and Special Meeting of Shareholders and Effective Date for Legal Name Change
Cybin Inc. To Officially Change Name To Helus Pharma Inc. Effective October 1, 2026
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.